The bovine papillomavirus constitutive enhancer is essential for viral transformation, DNA replication, and the maintenance of latency - PubMed (original) (raw)

The bovine papillomavirus constitutive enhancer is essential for viral transformation, DNA replication, and the maintenance of latency

S B Vande Pol et al. J Virol. 1992 Apr.

Abstract

Bovine papillomavirus type 1 (BPV-1) has served as the prototype papillomavirus for the study of viral transcription, DNA replication, and latency. However, no cis essential transcription control regions which are necessary for both transformation and replication of BPV-1 or any other papillomavirus have yet been defined. We have found that BPV-1 mutants with deletions in the long control region were defective for transformation and replication, with the essential region in the 5' long control region corresponding to the previously defined BPV-1 constitutive enhancer (S. B. Vande Pol and P. M. Howley, J. Virol. 64:5420-5429, 1990). BPV-1 mutants deleted of the constitutive enhancer could be complemented in trans by the full-length virally encoded E2 transactivator and replication factor (E2TA) and in cis by the simian virus 40 enhancer. The constitutive enhancer induced the production of E2TA by activating all the major viral early promoters upstream of the E2 open reading frame. Complementation experiments using a temperature-sensitive E2TA mutant indicated that the constitutive enhancer was necessary for the maintenance of viral DNA replication within latently infected cells and implied that viral transcription under the regulation of the constitutive enhancer may be controlled during the cell cycle. The constitutive enhancer is a master regulatory control region for establishing and maintaining BPV-1 latency, and its characteristics reveal some analogies with cell type-specific enhancer elements recognized in the human papillomaviruses.

PubMed Disclaimer

Cited by

DNA replication of human papillomavirus type 31 is modulated by elements of the upstream regulatory region that lie 5' of the minimal origin.
Hubert WG, Kanaya T, Laimins LA. Hubert WG, et al. J Virol. 1999 Mar;73(3):1835-45. doi: 10.1128/JVI.73.3.1835-1845.1999. J Virol. 1999. PMID: 9971761 Free PMC article.
Transformation by bovine papillomavirus type 1 E6 is independent of transcriptional activation by E6.
Ned R, Allen S, Vande Pol S. Ned R, et al. J Virol. 1997 Jun;71(6):4866-70. doi: 10.1128/JVI.71.6.4866-4870.1997. J Virol. 1997. PMID: 9151888 Free PMC article.
The adenovirus E3-14.7K protein and the E3-10.4K/14.5K complex of proteins, which independently inhibit tumor necrosis factor (TNF)-induced apoptosis, also independently inhibit TNF-induced release of arachidonic acid.
Krajcsi P, Dimitrov T, Hermiston TW, Tollefson AE, Ranheim TS, Vande Pol SB, Stephenson AH, Wold WS. Krajcsi P, et al. J Virol. 1996 Aug;70(8):4904-13. doi: 10.1128/JVI.70.8.4904-4913.1996. J Virol. 1996. PMID: 8763993 Free PMC article.
Targeted mutagenesis of the human papillomavirus type 16 E2 transactivation domain reveals separable transcriptional activation and DNA replication functions.
Sakai H, Yasugi T, Benson JD, Dowhanick JJ, Howley PM. Sakai H, et al. J Virol. 1996 Mar;70(3):1602-11. doi: 10.1128/JVI.70.3.1602-1611.1996. J Virol. 1996. PMID: 8627680 Free PMC article.
Cis and trans requirements for stable episomal maintenance of the BPV-1 replicator.
Piirsoo M, Ustav E, Mandel T, Stenlund A, Ustav M. Piirsoo M, et al. EMBO J. 1996 Jan 2;15(1):1-11. EMBO J. 1996. PMID: 8598191 Free PMC article.

References

1. J Virol. 1991 Feb;65(2):743-53 - PubMed
1. EMBO J. 1991 Feb;10(2):449-57 - PubMed
1. Cell. 1991 May 3;65(3):493-505 - PubMed
1. Genes Dev. 1990 Jan;4(1):123-36 - PubMed
1. J Virol. 1990 Jun;64(6):2849-59 - PubMed

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

The bovine papillomavirus constitutive enhancer is essential for viral transformation, DNA replication, and the maintenance of latency - PubMed (original) (raw)